Parkinson’s gene therapy could improve motor symptoms

News

Author: Simge Eva DoganPublished: 14 November 2018

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Young medical researcher

UK researchers are trialling an innovative gene therapy that could improve motor symptoms – such as tremors and rigidity – experienced by people with Parkinson’s.

The therapy, named AXO-Lenti-PD, has been developed by biopharmaceutical companies Oxford BioMedica and Axovant Sciences.

The trial will work with 30 participants living with Parkinson’s at hospitals in London and Cambridge, UK and Paris, France. The first stage will evaluate the safety and dosage of the therapy – and the second stage will assess the long-term effects of the therapy on motor function.

To read more on this topic click here.

For more information on Parkinson’s and gene therapy please visit the EPDA website.


Read more:

Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

AI technology could diagnose Parkinson’s in less than three minutes

Go Back

Share this story

Comments


Related articles


Levodopa inhaler lead

Advances

New levodopa ‘inhaler’ designed to eliminate ‘off’ times

Phase III clinical trial tests new inhaled form of levodopa

READ MORE

Interviews

Paint relief: “The joy of painting outshines my Parkinson’s symptoms”

Self-taught artist Walter Reynecke on how painting calms his condition

READ MORE
Speech therapy

PD in Practice

6 tips for improving speech in Parkinson’s

How to get the most from speech therapy sessions with PwPs

READ MORE